Experts are convinced that epigenetics will play a key role in the fight against cancer
First edition of the "Barcelona Conference on Epigenetics and Cancer: Challenges, Opportunities and Perspectives", which will be held over the coming five years and aspires to become a global benchmark in this field.
By Biocat
B·Debate and the Institute of Predictive and Personalized Medicine of Cancer (IMPPC) have called together leading national and international cancer researchers on 21 and 22 November at CosmoCaixa Barcelona in order to discuss the fundamental aspects of cancer biology and epigenetics and the possibilities for exploiting this knowledge to develop new treatments.
The Barcelona Conference on Epigenetics and Cancer: Challenges, Opportunities and Perspectives is the first in a series of conferences that will take place in Barcelona over the coming five years that aspire to become a global benchmark in this field. The scientific directors for the first edition, which will have more than 400 participants, are Dr. Manuel Perucho, researcher and director of the IMPPC, and Dr. Marcus Buschbeck, head of the IMPPC workgroup on the epigenetics of cancer.
More information on the B·Debate website.
Follow us on Twitter @bdebate with the hashtags #BDebate #cancer.
Date: 21 and 22 of November 2013
Place: CosmoCaixa • C/ Isaac Newton, 26 • Barcelona (map)
- Report on the debate (25 November 2013)
- Press release (18/11/2013)
- News on other B·Debate activities
| Organizers: |
  |
| Collaborators: |
     |